Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Captor Therapeutics SA (60Q) Stock Price & Analysis

1 Followers

60Q Stock Chart & Stats

€11.62-€0.04(-0.34%)
At close: 5:30 PM GMT+1
€18.6€18.63€18.65Jan 21Jan 22
Day’s Range
EUR 11.44 - EUR 11.68
52-Week Range
EUR 9.88 - EUR 20.90
Previous Close
EUR 11.66
Volume
N/A
Average Volume (3M)
0
Market Cap
EUR 75.70M
Enterprise Value
EUR 396.61M
Total Cash (Recent Filing)
EUR 71.50M
Total Debt (Recent Filing)
EUR 2.66M
Price to Earnings (P/E)
―
Beta
0.43
Next Earnings
Dec 02, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Proprietary Technology Platform

Captor Therapeutics' TPD platform offers a unique approach to drug development, potentially providing a competitive edge in creating novel therapies for oncology and autoimmune diseases.

Strategic Partnerships

Strategic partnerships provide funding and potential revenue streams, supporting R&D efforts and enhancing the company's ability to advance its drug candidates through clinical trials.

Revenue Diversification

Licensing agreements diversify revenue streams, reducing reliance on a single income source and potentially increasing financial stability as the company progresses in its development pipeline.

Bears Say

Declining Revenue

A significant decline in revenue growth poses a challenge to financial sustainability, impacting the company's ability to fund operations and invest in future growth opportunities.

Negative Cash Flow

Consistent negative cash flows limit financial flexibility, potentially hindering the company's capacity to invest in R&D and scale its operations effectively.

Profitability Challenges

Ongoing profitability issues, such as negative net profit margins, highlight operational inefficiencies and may affect long-term viability if not addressed.

60Q FAQ

What was Captor Therapeutics SA’s price range in the past 12 months?
Captor Therapeutics SA lowest stock price was €9.88 and its highest was €20.90 in the past 12 months.
What is Captor Therapeutics SA’s market cap?
Captor Therapeutics SA’s market cap is €75.70M.
When is Captor Therapeutics SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Captor Therapeutics SA’s earnings last quarter?
Captor Therapeutics SA released its earnings results on Sep 03, 2026. The company reported -€0.412 earnings per share for the quarter.
Is Captor Therapeutics SA overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Captor Therapeutics SA pay dividends?
Captor Therapeutics SA does not currently pay dividends.
What is Captor Therapeutics SA’s EPS estimate?
Captor Therapeutics SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Captor Therapeutics SA have?
Captor Therapeutics SA has 6,362,331 shares outstanding.
What happened to Captor Therapeutics SA’s price movement after its last earnings report?
Captor Therapeutics SA reported an EPS of -€0.412 in its last earnings report. Following the earnings report the stock price went up 1.847%.
Which hedge fund is a major shareholder of Captor Therapeutics SA?
Currently, no hedge funds are holding shares in DE:60Q
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology